US FDA Novel Approvals Total 35 In First Half 2023, Riding Resurgent Biologics Wave
US FDA’s drug center clears 26 novel agents, changing course from 2022’s disappointing first half, while the biologics center’s smashed two decades of records with nine novel approvals in six months.
